企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
BNC KOREA, Inc. and its consolidated subsidiaries have, since their establishment in 2007, engaged in the research and development of strategic application products set to lead the next-generation bio market, such as medical devices, anti-aging beauty devices, pharmaceuticals, and cosmeceutical products, by processing biomaterials such as hyaluronic acid and collagen, as well as the distribution of diagnostic reagents and testing equipment. The company's main products include HA fillers using hyaluronic acid, biopharmaceuticals using botulinum toxin, anti-adhesion materials, and collagen-absorbable wound dressings using collagen, all of which are classified as medical devices.
代表理事
Choi Wangyu
成立日期
2016年10月14日
法人类型
韩国创业板
行业分类
Manufacture of medicinal chemicals
法人注册号
11011-6202305
营业执照号
404-86-00676
电话号码
070-7116-0059
传真号码
053-592-0152
公司地址
62 Seongseogongdan-ro 11-gil, Dalseo-gu, Daegu
产品与服务
评论